We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Ericsson
ERIC
$33.3B
| $267K | ﹤0.01% |
+48,939
| New | +$263K |
|
2952
Altimmune
ALT
$599M
| $265K | ﹤0.01% |
+75,072
| New | +$337K |
|
|
NSTG
2953
DELISTED
NanoString Technologies, Inc.
NSTG
| $264K | ﹤0.01% |
65,304
-1,843
| -3% | -$13.6K |
|
2954
Century Casinos
CNTY
$34M
| $264K | ﹤0.01% |
37,231
-821
| -2% | -$5.82K |
|
2955
Capital Bancorp
CBNK
$615M
| $264K | ﹤0.01% |
14,602
+218
| +2% | +$3.73K |
|
|
PAMT
2956
PAMT Corp
PAMT
$297M
| $264K | ﹤0.01% |
9,856
+795
| +9% | +$20.3K |
|
2957
Douglas Elliman
DOUG
$162M
| $264K | ﹤0.01% |
118,832
-121,792
| -51% | -$334K |
|
2958
Parke Bancorp
PKBK
$405M
| $263K | ﹤0.01% |
15,491
+328
| +2% | +$5.5K |
|
|
TBCH
2959
Turtle Beach Corp
TBCH
$277M
| $263K | ﹤0.01% |
22,583
+1,107
| +5% | +$12.3K |
|
2960
Acacia Research
ACTG
$470M
| $262K | ﹤0.01% |
+62,960
| New | +$254K |
|
2961
Quad
QUAD
$525M
| $261K | ﹤0.01% |
69,433
-4,119
| -6% | -$14.9K |
|
2962
Crawford & Co Class A
CRD.A
$669M
| $260K | ﹤0.01% |
23,482
-2,944
| -11% | -$28.4K |
|
2963
Veritone
VERI
$122M
| $258K | ﹤0.01% |
65,941
+24,884
| +61% | +$109K |
|
2964
Ovid Therapeutics
OVID
$491M
| $258K | ﹤0.01% |
+78,768
| New | +$267K |
|
2965
Hooker Furnishings Corp
HOFT
$166M
| $258K | ﹤0.01% |
+13,829
| New | +$235K |
|
|
VE
2966
DELISTED
VEOLIA ENVIRONNEMENT
VE
| $258K | ﹤0.01% |
+16,201
| New | +$258K |
|
2967
Manulife Financial
MFC
$73.5B
| $258K | ﹤0.01% |
+13,625
| New | +$260K |
|
2968
Magna International
MGA
$18.8B
| $257K | ﹤0.01% |
+4,547
| New | +$241K |
|
|
USX
2969
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $256K | ﹤0.01% |
+41,770
| New | +$253K |
|
2970
Smith & Nephew
SNN
$12.6B
| $256K | ﹤0.01% |
+7,929
| New | +$245K |
|
|
THRX
2971
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $255K | ﹤0.01% |
27,297
+1,475
| +6% | +$14.5K |
|
2972
Mineralys Therapeutics
MLYS
$2.41B
| $254K | ﹤0.01% |
14,895
+3,935
| +36% | +$58.8K |
|
|
GRTS
2973
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $254K | ﹤0.01% |
+130,053
| New | +$305K |
|
2974
Colony Bankcorp
CBAN
$467M
| $253K | ﹤0.01% |
26,869
-424
| -2% | -$4.03K |
|
2975
Silvercrest Asset Management
SAMG
$79.9M
| $252K | ﹤0.01% |
12,467
-439
| -3% | -$8.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.